Publications by authors named "J P Metges"

Claim this Profile
T
TRYBECA-1: A Randomized Phase III Study of Eryaspase Combined With Chemotherapy Versus Chemotherapy as Second-Line Treatment in Patients With Advanced Pancreatic Adenocarcinoma.
Pascal Hammel, Jean-Philippe Metges, Teresa Macarulla Mercade, Rocio Garcia-Carbonero, Olivier Bouché

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer: 5-year extended follow-up for the randomized phase III KEYNOTE-590 study.
J-P Metges, K Kato, J-M Sun, L Shen, P C Enzinger

ESMO Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Streptozotocin plus 5-fluorouracil followed by everolimus or the reverse sequence in patients with advanced pancreatic neuroendocrine tumors (SEQTOR-GETNE phase III study): a randomized clinical trial.
J Capdevila, S Tafuto, M Krogh, A Teulé, R Garcia-Carbonero, J-P Metges

ESMO Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zanidatamab in HER2-Positive Metastatic Biliary Tract Cancer: Final Results From HERIZON-BTC-01.
Shubham Pant, Jia Fan, Do-Youn Oh, Hye Jin Choi, Jin Won Kim, Jean-Phillippe Metges

JAMA Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative red blood cell transfusion following high-risk oncologic surgery for tumor resection: a systematic review and meta-analysis.
Xavier Chapalain, Morgane Zaïna, Jean-Philippe Metges, Bogdan Badic, Rosemary L Sparrow

Transfus Clin Biol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis